Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


UCL Enterprise App

UCL Enterprise app

UCL has an extensive set of events and resources supporting entrepreneurs and new businesses and the app was created to help access the ones that might be best for you.

The app draws in feeds from several different sources to highlight the best of our news, events and video content.

Download the UCL Enterprise App from iTunes

Google Play and Windows 8 options coming soon.

Enterprise app screen shotEnterprise app screen shot

Developed by: Richard Groves (MSc Computer Science, 1992), Dr Alastair Moore (EngD, 2012) from an idea by Timothy Barnes (BA History, 1997) and Dr David Chapman (Vice Dean (Enterprise), Engineering Sciences).